This analysis indicated that up to 29% of bladder cancers have nonsense or truncating mutations in ARID1A (Supplemental Figure 1A; supplemental material available online with this article; https://doi.org/10.1172/jci.insight.155899DS1). This evidence concerns the gene ARID1A and urinary bladder carcinoma.